These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The novel hormone INSL3 is expressed in human testicular Leydig cell tumors: a clinical and immunohistochemical study. Rossato M; Tavolini IM; Calcagno A; Gardiman M; Dal Moro F; Artibani W Urol Oncol; 2011; 29(1):33-7. PubMed ID: 19110449 [TBL] [Abstract][Full Text] [Related]
3. Expression patterns of DLK1 and INSL3 identify stages of Leydig cell differentiation during normal development and in testicular pathologies, including testicular cancer and Klinefelter syndrome. Lottrup G; Nielsen JE; Maroun LL; Møller LM; Yassin M; Leffers H; Skakkebæk NE; Rajpert-De Meyts E Hum Reprod; 2014 Aug; 29(8):1637-50. PubMed ID: 24908673 [TBL] [Abstract][Full Text] [Related]
4. Abundance of DLK1, differential expression of CYP11B1, CYP21A2 and MC2R, and lack of INSL3 distinguish testicular adrenal rest tumours from Leydig cell tumours. Lottrup G; Nielsen JE; Skakkebæk NE; Juul A; Rajpert-De Meyts E Eur J Endocrinol; 2015 Apr; 172(4):491-9. PubMed ID: 25609776 [TBL] [Abstract][Full Text] [Related]
5. Leydig cell hyperplasia in children: Case series and review. Mennie N; King SK; Marulaiah M; Ferguson P; Heloury Y; Kimber C J Pediatr Urol; 2017 Apr; 13(2):158-163. PubMed ID: 28238607 [TBL] [Abstract][Full Text] [Related]
6. Calretinin: a valuable marker of normal and neoplastic Leydig cells of the testis. Augusto D; Leteurtre E; De La Taille A; Gosselin B; Leroy X Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):159-62. PubMed ID: 12051635 [TBL] [Abstract][Full Text] [Related]
7. Leydig cell tumors of the testis with unusual features: adipose differentiation, calcification with ossification, and spindle-shaped tumor cells. Ulbright TM; Srigley JR; Hatzianastassiou DK; Young RH Am J Surg Pathol; 2002 Nov; 26(11):1424-33. PubMed ID: 12409718 [TBL] [Abstract][Full Text] [Related]
8. Comparative molecular analysis of testicular Leydig cell tumors demonstrates distinct subsets of neoplasms with aggressive histopathologic features. Rizzo NM; Sholl LM; Idrees MT; Cheville JC; Gupta S; Cornejo KM; Miyamoto H; Hirsch MS; Collins K; Acosta AM Mod Pathol; 2021 Oct; 34(10):1935-1946. PubMed ID: 34103665 [TBL] [Abstract][Full Text] [Related]
9. Utility of immunostaining for S-100 protein subunits in gonadal sex cord-stromal tumors, with emphasis on the large-cell calcifying Sertoli cell tumor of the testis. Tanaka Y; Carney JA; Ijiri R; Kato K; Miyake T; Nakatani Y; Misugi K Hum Pathol; 2002 Mar; 33(3):285-9. PubMed ID: 11979368 [TBL] [Abstract][Full Text] [Related]
10. Steroidogenic acute regulatory protein is a useful marker for Leydig cells and sex-cord stromal tumors. Dong L; Wang H; Su Z; Niu S; Wang R; Wu L; Chen G Appl Immunohistochem Mol Morphol; 2011 May; 19(3):226-32. PubMed ID: 21217523 [TBL] [Abstract][Full Text] [Related]
11. Rodent Leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms, and relevance to humans. Cook JC; Klinefelter GR; Hardisty JF; Sharpe RM; Foster PM Crit Rev Toxicol; 1999 Mar; 29(2):169-261. PubMed ID: 10213111 [TBL] [Abstract][Full Text] [Related]
12. Inhibin-alpha CD99, HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen insensitivity syndrome. Kommoss F; Oliva E; Bittinger F; Kirkpatrick CJ; Amin MB; Bhan AK; Young RH; Scully RE Hum Pathol; 2000 Sep; 31(9):1055-61. PubMed ID: 11014571 [TBL] [Abstract][Full Text] [Related]
13. Non-tumoural parenchyma in Leydig cell tumours: pathogenetic considerations. Cajaiba MM; Reyes-Múgica M; Rios JC; Nistal M Int J Androl; 2008 Jun; 31(3):331-6. PubMed ID: 17573846 [TBL] [Abstract][Full Text] [Related]
14. β-Catenin alterations in testicular Leydig cell tumour: a immunohistochemical and molecular analysis. Kitagawa Y; De Biase D; Ricci C; Cornejo KM; Fiorentino M; Collins K; Idrees MT; Colecchia M; Ulbright TM; Acosta AM Histopathology; 2024 Jul; 85(1):75-80. PubMed ID: 38530207 [TBL] [Abstract][Full Text] [Related]
15. Origin and evolution of somatic cell testicular tumours in transgenic mice. Quintana S; Venara M; Rey R; di Clemente N; Chemes HE J Pathol; 2010 Aug; 221(4):443-51. PubMed ID: 20593483 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical evaluation of GATA-4 in canine testicular tumors. Ramos-Vara JA; Miller MA Vet Pathol; 2009 Sep; 46(5):893-6. PubMed ID: 19429994 [TBL] [Abstract][Full Text] [Related]
17. Switch of cadherin expression as a diagnostic tool for Leydig cell tumours. Bremmer F; Schweyer S; Martin-Ortega M; Hammerlein B; Strauss A; Radzun HJ; Behnes CL APMIS; 2013 Oct; 121(10):976-81. PubMed ID: 23398382 [TBL] [Abstract][Full Text] [Related]
18. Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boys. Abiuso AMB; Varela ML; Haro Durand L; Besio Moreno M; Marcos A; Ponzio R; Rivarola MA; Belgorosky A; Pignataro OP; Berensztein E; Mondillo C Eur J Cancer; 2018 Mar; 91():125-135. PubMed ID: 29367056 [TBL] [Abstract][Full Text] [Related]
19. Expression analyses of insulin-like peptide 3, RXFP2, LH receptor, and 3β-hydroxysteroid dehydrogenase in testes of normal and cryptorchid dogs. Hannan MA; Kawate N; Kubo Y; Pathirana IN; Büllesbach EE; Hatoya S; Inaba T; Takahashi M; Tamada H Theriogenology; 2015 Oct; 84(7):1176-84. PubMed ID: 26220663 [TBL] [Abstract][Full Text] [Related]
20. Human testicular insulin-like factor 3: in relation to development, reproductive hormones and andrological disorders. Bay K; Andersson AM Int J Androl; 2011 Apr; 34(2):97-109. PubMed ID: 20550598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]